Evommune, Inc.
EVMNBiotechnology
$6.81+7.92%As of Oct 29vs prior close
- Market cap
- $247.1M
- P/E (TTM)
- –
- From 52W high
- −78.43%
- EPS (LTM)
- $5.53
- Revenue (LTM)
- $10M
- Net margin
- -946.68%
- Dividend yield
- 0.00%
Nomior Score
30
Steady ProfileSpeculativeBottom 15% of the scored universe
Growth43
Quality36
Value35
Momentum—
Resilience31
Growth
+85.71%revenue a year over 1 fiscal year
YE24 $7MLTM $10M
Connections
Revenue to profitQ3 YE25
The operating loss was 133% of revenue.
Who owns it
2funds